Extrapyramidal side effects associated with aripiprazole administration in a schizophrenic patient [2]

Pharmacopsychiatry

Volumn 40, Issue 2, 2007, Pages 83-84

  Hung, Galen Chin Lun ^a   Chen, Ying Yeh ^a,b,c  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NONE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BIPERIDEN; PROPRANOLOL; RISPERIDONE; SERTRALINE; VENLAFAXINE;

ADULT; AKATHISIA; BRADYKINESIA; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYMPTOM; GAIT DISORDER; HUMAN; LETTER; MALE; MASK LIKE FACE; MUSCLE RIGIDITY; PARKINSONISM; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADULT; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; HUMANS; MALE; PARKINSONIAN DISORDERS; PIPERAZINES; QUINOLONES; SCHIZOPHRENIA;

EID: 34247850776     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-970060     Document Type: Letter

References (5)

1. Cohen S, Rulf D, Pies R: Extrapyramidal side effects associated with aripiprazole coprescription in two patients. J Clin Psychiatry 2005; 66: 135-136
2. Desarkar P, Thakur A, Sinha VK: Aripiprazole-induced acute dystonia. Am J Psychiatry 2006; 163: 1112-1113
3. Grunder G, Kungel M, Ebrecht M et al: Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia. Pharmacopsychiatry 2006; 39 (1, Suppl): S21-S25
4. Mobascher A, Mobascher J, Schlemper V, Winterer G, Malevani J: Aripiprazole pharmacotherapy of borderline personality disorder. Pharmacopsychiatry 2006; 39: 111-112
5. Sharma A, Sorrell JH: Aripiprazole-induced parkinsonism. Int Clin Psychopharmacol 2006; 21: 127-129